In an 8-week, dose comparison trial involving five fixed doses of risperidone (1, 4, 8, 12, and 16 mg/ day administered twice-daily), the 4, 8, and 16 mg/ day risperidone dose groups were superior to the 1 mg risperidone dose group on PANSS total score.